A Phase 4 interventional study of Bupivacaine-epinephrine and Normal saline in Post Thoracic Surgery, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre. Completed at 1 site in Canada. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-03-05.
Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre · Phase 4, Interventional, and Treatment
While thoracic epidural could control incisional pain after thoracotomy, an excruciating ipsilateral shoulder pain happens post thoracotomy and could affect up to 85% of thoracotomy patients. It is often difficult to manage and relatively resistant to opioids. The investigators postulate that in the presence of a functioning thoracic epidural, intrapleural bupivacaine administered through the chest tube could be effective in reducing post thoracotomy ipsilateral shoulder pain.
707 studies on the registry are indexed under Shoulder Pain; 152 are open to participants now.
This study's enrollment of 42 is below the median of 60 across 561 interventional studies indexed under Shoulder Pain.
Browse Shoulder Pain studies →McGill University Health Centre/Research Institute of the McGill University Health Centre is the lead sponsor of 415 studies on the registry; 106 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients in this group receive Normal Saline injection in the inter pleural space
Drug: Normal saline
Patients in this group receive Bupivacaine 0.25% + Epinephrine 5 mcg/ml injection in the inter pleural space
Drug: Bupivacaine-epinephrine
See previous description
See previous descreption
Change in VAS scores
ISP visual analogue scale scores before intrapleural block and at 30 min, 4 hours and 24 hours
Time frame: from 0 hour to 24 hour
Forced Vital Capacity
Time frame: from 0 hour to 48 hour
Total epidural infusion
Time frame: from 0 hour to 48 hour
Co-analgesia consumption
Time frame: from 0 hour to 48 hour
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
McGill University Health Centre/Research Institute of the McGill University Health Centre